Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting
-
Fractyl Health to Present Compelling Preclinical Data from its Rejuva® Single-Administration Smart GLP-1 Pancreatic Gene Therapy Platform at the American Society of Gene and Cell Therapy (ASGCT) 2025
-
Shape Therapeutics Announces Multiple Oral and Poster Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting
-
Axovia Therapeutics Announces Three Upcoming Poster Presentations at ASGCT
-
Macerich Declares the Quarterly Dividend on Its Common Shares
-
Spur Therapeutics Announces Oral and Poster Presentations Highlighting Data from Clinical and Preclinical Programs at Upcoming ASGCT Annual Meeting
-
Portillo’s Announces Plan to Further Strengthen Board Through Cooperation Agreement with Engaged Capital
-
Gladius Global Advisors Announces Manny Abin as CEO, Bringing Asset Management Expertise and Innovation to the Table
-
Ebang International Reports Financial Results for Fiscal Year 2024
-
Cohen & Company Sets Release Date for First Quarter 2025 Financial Results
-
Transocean Ltd. Reports First Quarter 2025 Results
-
Cohen & Company Sets Release Date for First Quarter 2025 Financial Results
-
Powell Max Limited Announces 2024 Audited Financial Results
-
Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A
-
SPAR Group, Inc. Receives Nasdaq Notice of Late Filing of its Form 10-K
-
Two Senior Executives Join the Diginex Team to Drive Sustainable Finance Initiatives and strategic M&A
-
Turtle Beach Corporation to Report First Quarter 2025 Financial Results on Thursday, May 8, 2025
-
Piedmont Office Realty Trust, Inc. Releases First Quarter 2025 Results
-
Amarin to Report First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
-
NXP Semiconductors Reports First Quarter 2025 Results, Announces Management Transition
-
Palomar Holdings, Inc. Announces First Quarter 2025 Financial Results Release Date and Conference Call
-
GENFIT: positive late-breaking Phase 2 data for elafibranor in Primary Sclerosing Cholangitis (PSC) to be presented by Ipsen at EASL Congress 2025
-
Countdown to CoinW’s TOKEN2049 side event: Navigating Dubai’s policy landscape and crypto’s future
-
Notice to Long-Term Shareholders of Integra Lifesciences Holdings Corporation (NASDAQ: IART); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Virtu Financial
-
Rigetti Computing to Report First Quarter 2025 Financial Results and Host Conference Call on May 12, 2025
-
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025
-
First Watch Acquires 16 Franchise Restaurants in North and South Carolina
-
EZCORP Reports Second Quarter Fiscal 2025 Results
-
BriaCell Therapeutics Announces Closing of $13.8 million Public Offering
-
Financial Institutions, Inc. Announces First Quarter 2025 Results
-
LifeMD to Report First Quarter 2025 Financial Results on May 6
-
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025
-
Kane Biotech Announces Fourth Quarter and Full Year 2024 Financial Results, Narrows Strategic Focus and Makes Leadership Change
-
Pool Corporation to Present at the Oppenheimer 20th Annual Industrial Growth Conference
-
Clearway Signs 335 MW Power Purchase Agreement with Microsoft
-
Clearway Signs 335 MW Power Purchase Agreement with Microsoft
-
Tempest Presents New Amezalpat MOA Data Reinforcing Its Potential as Novel Cancer Treatment at the 2025 AACR Annual Meeting
-
CytoMed Therapeutics Reports Full Year Ended December 31, 2024 Financial Results and Provides Clinical and Corporate Updates
-
Results of Operations for the Year Ended December 31, 2024 - American Overseas Group Limited Announces Net Income Of $9.4 Million For the Year Ended December 31, 2024
-
Foghorn Therapeutics Presents New Preclinical Data on Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Programs and Provides Pipeline Update
-
VirTra Sets First Quarter 2025 Conference Call for Monday, May 12, 2025 at 4:30 p.m. ET
-
Metropolitan Water District of Southern California Uses BetterFleet Software to Manage Charging in Zero-Emission Fleet Transition
-
Bicara Therapeutics Highlights Broad Potential of Ficerafusp Alfa at AACR Annual Meeting 2025
-
Skyward Specialty Announces Time Change for First Quarter Earnings Call on Friday, May 2, 2025
-
Astec Announces Quarterly Dividend
-
Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call
-
Capital Southwest Announces Regular Dividend of $0.58 per share and Supplemental Dividend of $0.06 per share for the Quarter Ending June 30, 2025
-
Spero Therapeutics Appoints Esther Rajavelu as President and Chief Executive Officer
-
MYR Group Inc. to Attend KeyBanc Industrials & Basic Materials Conference in May
-
Woodward Reports Second Quarter Fiscal Year 2025 Results

